Biomarkers for Alzheimer’s disease: from pathogenesis to drug development Kenji Hashimoto Editorial 12 June 2018 Pages: 441 - 442
Articulation and testing of a personality-centred model of psychopathology: evidence from a longitudinal community study over 30 years Michael P. HengartnerPeter TyrerWulf Rössler Original Paper 07 April 2017 Pages: 443 - 454
The association of psychopathology with concurrent level of functioning and subjective well-being in persons with schizophrenia spectrum disorders Lisa HochstrasserStefan BorgwardtChristian G. Huber Original Paper 29 March 2017 Pages: 455 - 459
Effects of neonatal excitotoxic lesions in ventral thalamus on social interaction in the rat Rainer WolfHenrik DobrowolnyHerbert Schwegler Original Paper 30 March 2017 Pages: 461 - 470
Planning functioning and impulsiveness in obsessive–compulsive disorder Riccardo Maria MartoniRoberta de FilippisLaura Bellodi Original Paper 02 May 2017 Pages: 471 - 481
Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-d-aspartate glutamate receptor antibodies in dementias Mandy BusseRalf KunschmannStefan Busse Original Paper 08 February 2017 Pages: 483 - 492
Increased quinolinic acid in peripheral mononuclear cells in Alzheimer’s dementia Mandy BusseVanessa HettlerStefan Busse Original Paper 06 April 2017 Pages: 493 - 500
Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer’s disease patients Alana C. CostaHelena P. G. JoaquimLeda Leme Talib Original Paper 31 August 2017 Pages: 501 - 507
No difference in the prevalence of Alzheimer-type neurodegenerative changes in the brains of suicides when compared with controls: an explorative neuropathologic study Jakob MatschkeSusanne SehnerMarkus Glatzel Original Paper 30 January 2018 Pages: 509 - 517
Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease Panagiotis AlexopoulosLena-Sophie GleixnerRobert Perneczky Short Communication 10 June 2017 Pages: 519 - 524